Results 181 to 190 of about 40,111 (286)

A 60 Year Old Man with Activated Partial Thromboplastin Time without Hemorrhagic Tendency

, 2008
Fumio Maruyama, Nobuhiko Emi
openalex   +2 more sources

Non‐Invasive Stratification of Portal Hypertension in Patients With BCR::ABL1‐Negative Myeloproliferative Neoplasms

Liver International, Volume 45, Issue 6, June 2025.
ABSTRACT Background & Aims The course of BCR::ABL1‐negative myeloproliferative neoplasms (MPN) is frequently complicated by thromboembolic events in the splanchnic venous system, resulting in portal hypertension (PH). Therefore, the introduction of spleen stiffness measurement (SSM) might improve the diagnosis of PH.
Lorenz Balcar, Lina Degenfeld‐Schonburg, Can Hopp, Georg Kramer, Irene Graf, Lucie Simonis, Christian Sillaber, Stephanie Kalteis, Heinz Gisslinger, Tobias Meischl, Albert Friedrich Stättermayer, Mattias Mandorfer, Gerlinde Mitterbauer‐Hohendanner, Thomas Reiberger, Michael Trauner, Bernhard Scheiner, Maria‐Theresa Krauth, Georg Semmler   +17 more
wiley   +1 more source

Standardization of Coagulation Factor V Reference Intervals, Prothrombin Time, and Activated Partial Thromboplastin Time in Mice for Use in Factor V Deficiency Pathological Models. [PDF]

Front Vet Sci, 2022
De Pablo-Moreno JA, Liras A, Revuelta L.
europepmc   +1 more source

Measurement of Prothrombin Time (PT) and Activated Partial Thromboplastin Time (APTT), Fibrinogen Level, D-Dimer in Sudanese Infants and Children with Sepsis Khartoum State, 2022

, 2022
Mohamed Hassan Osman Ebar, Alia bushra Osman Mohamed, Remaz Ahmed Alamen Mohamed Abdalla, Maye M. Merghani, Nihad alsadig Babiker   +4 more
openalex   +2 more sources

Dexmedetomidine Reduces Chronic Stress–Related Thrombosis in a Mouse FeCl3 Model

The FASEB Journal, Volume 39, Issue 9, 15 May 2025.
Schematic summary of the mechanism by which dexmedetomidine prevents chronic stress–related carotid artery thrombosis in a mouse FeCl3 model. These findings present evidence and a potential mechanistic explanation of the Dex‐mediated amelioration of arterial thrombosis associated with the reduction of oxidative stress, inflammation, and apoptosis, and ...
Huazhen Wang, Meiping Zhang, Minglong Xin, Xueling Yue, Jinshun Piao, Longguo Zhao, Hehui Bi, Shiyan Wang, Chunzi Jin, Yongshan Nan, Xianglan Jin, Xian Wu Cheng   +11 more
wiley   +1 more source

Coagulation factors in spray‐dried plasma: A systematic review and meta‐analysis

Transfusion, EarlyView.
Biswadev Mitra, Patrick J. C. Biggins, Denese C. Marks, Michael C. Reade   +3 more
wiley   +1 more source

Identification of Risk Factors Influencing Hemorrhage Volume in Aneurysmal Subarachnoid Hemorrhage: A Multicenter Retrospective Study

Brain and Behavior, Volume 15, Issue 5, May 2025.
Early identification and management of some risk factors can improve clinical outcomes and reduce the risk of bleeding complications. ABSTRACT Objective This multicenter retrospective study aimed to identify significant risk factors influencing hemorrhage volume in patients with aneurysmal subarachnoid hemorrhage (SAH).
Chenglong Li, Yuan Wang, Tangming Peng, Jiangnan Wu, Hongyu Wang, Jian Song, Di Zhao, Guang Feng, Lei Chen   +8 more
wiley   +1 more source

Association of prothrombin time, thrombin time and activated partial thromboplastin time levels with preeclampsia: a systematic review and meta-analysis. [PDF]

BMC Pregnancy Childbirth
Alemayehu E, Mohammed O, Belete MA, Mulatie Z, Debash H, Gedefie A, Weldehanna DG, Eshetu B, Shibabaw A, Tekele SG, Tilahun M, Ebrahim H.   +11 more
europepmc   +1 more source

A Recurrent Neural Network Model for Predicting Activated Partial Thromboplastin Time After Treatment With Heparin: Retrospective Study.

JMIR Med Inform, 2022
Boie SD, Engelhardt LJ, Coenen N, Giesa N, Rubarth K, Menk M, Balzer F.   +6 more
europepmc   +1 more source

Role of thromboelastography in the evaluation of septic shock patients with normal prothrombin time and activated partial thromboplastin time. [PDF]

Sci Rep, 2021
Kim SM, Kim SI, Yu G, Kim JS, Hong SI, Chae B, Shin YS, Kim YJ, Jang S, Kim WY.   +9 more
europepmc   +1 more source